2011 – Danish Medicines Agency approved medical use of cannabis derivatives.
Sativex, Marinol and Nabilone are available on prescription.
From 1st January, 2018 onward, medical cannabis products are available for Danish patients and are handed out from pharmacies and hospitals. This follows a parliamentary vote in December 2017 which approved a four-year trial for access to medical cannabis.
The Danish Medicines Agency has recommended four patient groups that can benefit from medical cannabis: multiple sclerosis, spinal cord injuries, chronic pain, and chemotherapy-induced nausea. However, a doctor is allowed to prescribe medical cannabis to patients with other conditions if it can be professionally justified.
Source: Healthcare Denmark